Myriad Genetics to join hands with Intermountain Precision Genomics to produce genetic testing devices for the global market.
The Centre for Ocular Research & Education (CORE) and Meso Scale Diagnostics, LLC announced the initiative to use the Meso Scale Discovery platform to identify biomarkers.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 3175
Published Date: Jul 28, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Rising prevalence of chronic diseases, such as cancer, and diabetes across the globe and the growing geriatric population are the major factors driving the growth of the market.
The market size of Predictive Biomarkers is anticipated to attain a CAGR of 20% over the forecast period, i.e., 2023 – 2035.
The major players in the market are Biomarker Technologies, Inc., Almac Group Limited, Myriad Genetics, Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, and others.
The research institutes segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
The market in the North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.